Physician profile
Dale E Dautenhahn
NPI 1649265422
$1,484.58
in general payments reported to CMS, 2019-2025
7 companies · $375 in 2025
The $375 reported for 2025 was more than what 89% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $54.99 · 2021: $222 · 2022: $125 · 2023: $152 · 2024: $386 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $912.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $925.74 | 2022-2025 | Impella |
| Edwards Lifesciences Corporation | $273.64 | 2019-2024 | Mitris Resilia Mitral Valve, Evoque |
| Chiesi USA, INC. | $178.59 | 2020-2025 | Cleviprex |
| Silk Road Medical, INC. | $41.38 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $34.81 | 2020-2025 | Bridion |
| Getinge USA Sales, LLC | $15.58 | 2020 | |
| Acacia Pharma INC | $14.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dale Dautenhahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.